Literature DB >> 14999624

False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value.

Alan R Katz1, Paul V Effler, Roy G Ohye, Barbara Brouillet, Maria Veneranda C Lee, Peter M Whiticar.   

Abstract

Five false-positive gonorrhea test results from a private laboratory using a nucleic acid amplification test led to an investigation by the Hawaii State Department of Health. No unexplained increase or variation in the laboratory's positive gonorrhea test results was detected. The proportion of positive gonorrhea test results among tests performed in the population was 1.06%. The calculated positive predictive value (PPV) of the test in this setting was 60%. Documentation of sexual histories was lacking for all cases. It is imperative to obtain a sexual history for both assessing sexually transmitted disease (STD) risk and interpreting STD test results. The possibility that positive test results may be false should be considered when patients have unanticipated positive test results. Clinicians who perform STD screening tests should know the approximate prevalence of STDs in the population being screened and have a conceptual understanding of PPV and the impact of low prevalence on screening tests with imperfect specificity.

Entities:  

Mesh:

Year:  2004        PMID: 14999624     DOI: 10.1086/381895

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae.

Authors:  Daniel Golparian; Stina Boräng; Martin Sundqvist; Magnus Unemo
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

2.  Gonorrhoea.

Authors:  C Bignell; C A Ison; E Jungmann
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

Review 3.  Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge.

Authors:  David M Whiley; John W Tapsall; Theo P Sloots
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

Review 4.  Laboratory results that should be ignored.

Authors:  Dirk M Elston
Journal:  MedGenMed       Date:  2006-10-11

Review 5.  Sexually transmitted infections: where are we now?

Authors:  C Robertson; A Jayasuriya; P S Allan
Journal:  J R Soc Med       Date:  2007-09       Impact factor: 5.344

Review 6.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR.

Authors:  C W M Geraats-Peters; M Brouwers; P M Schneeberger; A G M van der Zanden; S M Bruisten; G Weers-Pothoff; C H E Boel; A J C van den Brule; H G Harmsen; M H A Hermans
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 8.  Medical and legal implications of testing for sexually transmitted infections in children.

Authors:  Margaret R Hammerschlag; Christina D Guillén
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 9.  Gonorrhoea.

Authors:  Sarah Creighton
Journal:  BMJ Clin Evid       Date:  2014-02-21

10.  Neisseria species identification assay for the confirmation of Neisseria gonorrhoeae-positive results of the COBAS Amplicor PCR.

Authors:  Kathy A Mangold; MaryAnn Regner; Mohammed Tajuddin; Aamair M Tajuddin; Lawrence Jennings; Hongyan Du; Karen L Kaul
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.